PTSD News

ORLANDO, Fla. — In this video interview, Andrew Penn, RN, MS, NP, associate clinical professor at University of California, San Francisco, School of Nursing, discusses the session he presented at Psych Congress 2018, which offered an overview of three psychedelic medicines being used currently in psychiatric practice or in research.

Past deployment to Iraq or Afghanistan was linked to higher rates of common mental disorders and probable PTSD among ex-military service personnel in the United Kingdom, according to findings published in British Journal of Psychiatry.

In the United States, about one in three women and one in six men experienced some form of contact sexual violence during their lifetime, according to the CDC’s National Intimate Partner and Sexual Violence Survey 2010 to 2012 State Report.

A health economic study evaluating the financial impact of the GeneSight combinatorial pharmacogenomic test on major commercial health plans found that use of the test yielded reduced spending for a commercial health plan among patients with psychiatric disorders.

In clinical practice, evidence-based medications — fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine — were equally effective treatments for PTSD, according to data published in the Journal of Clinical Psychiatry.

Findings from a systematic review revealed a significant association between early childhood social adversity — including insecure attachment and adversity relating to neglect or abuse — and poorer social cognitive performance in participants with major psychiatric disorders.

Study findings showed that the percentage of active-duty female Air Force personnel experiencing PTSD symptoms increased as number of wartime experiences increased.

Study findings published in Depression & Anxiety showed that subthreshold PTSD accounted for a large proportion of a representative military cohort’s future PTSD burden.

Nearly 10% of men who were veterans with HF with reduced ejection fraction also had PTSD, according to a study published in The American Journal of Cardiology.

Veterans who completed a 3-week intensive outpatient program for daily cognitive processing therapy, mindfulness, yoga and psychoeducation saw large reductions in PTSD and depression symptoms, according to study findings.